Parents worried about breast milk contamination: What is best for baby?

Pediatric Clinics of North America

Volumn 48, Issue 5, 2001, Pages 1113-1127

  Schreiber, Judith S ^b  

^a Environmental Protection Bureau   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC COMPOUND;

ARTIFICIAL MILK; BREAST MILK; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; HOME; HUMAN; INFANT; INFANT FEEDING; NEWBORN; PARENTAL BEHAVIOR; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; WORKPLACE;

EID: 0034800951     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70364-3     Document Type: Article

References (84)

1. Minimal risk levels for priority substances and guidance for derivation
2. Transfer of drugs and other chemicals into human milk
3. Profiles of Great Lakes critical pollutants: A sentinel analysis of human blood and urine
4. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride
5. History and current status of infant feeding formulas
6. Drugs in human milk: Clinical pharmacokinetic considerations
7. History of infant feeding practices
8. Report of the SHO working group on the assessment of health risks for human infants from exposure to PCDDs, PCDFs and PCBs
9. "Occupational" exposure of infants to toxic chemicals via breast milk
10. Identification and follow-up of infants at risk of sudden death in infancy
11. Prevention of unexpected infant death
12. Development of a physiologically based pharmacokinetic model for chloroform
13. Twenty-five years of surveillance for contaminants in human breastmilk
14. Breast-feeding and health in the 1980s: A global epidemiologic review
15. Health, equity, and reproductive risks in the workplace
16. Environmental contaminants in milk: The problem of organochlorine xenobiotics
17. The Ojibwa Health Study: Fish residue comparisons for Lakes Superior, Michigan and Huron
18. High levels of PCBs in breast milk of Inuit women from Artic Quebec
19. A randomized study of the effects of aerobic exercise by lactating women on breast-milk volume and composition
20. Uptake and distribution
21. Prenatal exposure to polychlorinated biphenyls: Effects on birth size and gestational age
22. Lactational transfer of volatile chemicals in breast milk
23. Polychlorinated biphenyls (PCB) and dichlorodiphenyl dichloroethylene (DDE) exposure among Native American men from contaminated Great Lakes fish and wildlife
24. Transfer of persistent chemicals in milk
25. Drug passage into breast milk: Principles and concerns
26. Partition coefficients of low molecular-weight volatile chemicals in various liquids and tissues
27. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE)
28. Pubertal growth and development and prenatal and lactational exposure to polychorinated biphenyls and dichlorodiphenyl dichloroethene
29. Unnatural constituents of breast milk: Medication, lifestyle, pollutants, viruses
30. Relationships of lead in breast milk to lead in bone, urine, and diet of the infant and mother
31. Serum PCB levels and Great Lakes sport fish consumption
32. Time trends in sport-caught Great Lakes fish consumption and serum PCB levels, 1973-1993
33. Exposure to persistent organochlorines in Canadian breast milk: A probabilistic assessment
34. Perinatal exposure to polychlorinated biphenyls and dioxins and its effect on neonatal neurological development
35. Polychorinated dibenzo-p-dioxins and related compounds in breast milk of Japanese primiparas and multiparas
36. Effects of exposure to PCBs and related compounds on growth and activity in children
37. Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children
38. The effect of intrauterine PCB exposure on visual recognition memory
39. Chemical contaminants in human milk
40. Persistent organic pollutants in maternal blood plasma and breast milk from Russian Arctic populations
41. Perinatal lead and cadmium burden in a British urban population
42. Infant exposure to chemicals in breast milk in the United States: What we need to learn from a breast milk monitoring program
43. Methodology for characterizing distributions of incremental body burdens and 2,3,7,8-TCDD and DDE from breast milk in North American nursing infants
44. Given the benefits of breastfeeding, are there any contraindications?
45. Breastfeeding: A Guide for the Medical Professional
46. A review of the medial benefits and contraindications to breastfeeding in the United States
47. Breastfeeding: The use of recreational drugs-alcohol, caffeine, nicotine and marijuana
48. Neonatal behavioral assessment scale performance in humans influences by maternal consumption of environmentally contaminated Lake Ontario fish
49. Effects of exercise on plasma lipids and metabolism of lactating women
50. Weight change during lactation does not alter the concentrations of chlorinated organic contaminants in breast milk of women with low exposure
51. Lead in human blood and milk from nursing women living near a smelter in Mexico City
52. Fish Advisories in New York State
53. Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20-30 years
54. Medication use in the breastfeeding mother
55. Risk assessment in relation to neonatal metal exposure
56. Evidence that breastmilk protects against otitis media with effusion in infants with cleft palate
57. Reproductive hazards in the workplace: What the practitioner needs to know about chemical exposures
58. Analysis of reproductive health hazard information on material safety data sheets for lead and the ethylene glycol ethers
59. Drugs, toxins and environmental agents in breast milk
60. Mercury in human maternal and cord blood, placenta, and milk
61. Breast-feeding exposure of infants to selected pesticides: A pubic health viewpoint
62. A study of the conditions that require the removal of the child from the breast
63. The significance of drugs in breast milk
64. Should the presence of carcinogens in breast milk discourage breast feeding?
65. Environmental contaminants in breast milk
66. Prolonged breastfeeding as prophylaxis for recurrent otitis media
67. Developmental neurotoxicity of PCBs in humans: What do we know and where do we go from here?
68. Organochlorine residues in human breast milk: Analysis through a sentinel practice network
69. Residential exposure to volatile organic compounds from nearby commercial facilities
70. Transport of organic chemicals to breast milk: Tetrachloroethene case study
71. Assessment of reproductive disorders and birth defects in communities near hazardous chemical sites: II. Female reproductive disorders
72. Monitoring chemical exposure using breast milk: A methodological review
73. Mercury in women exposed to methylmercury through fish consumption and in their newborn babies and breast milk
74. Chemical contaminants in human milk: An overview
75. Pharmacokinetics of benzens
76. Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants
77. Report of the WHO working group on the assessment of health risks for human infants from exposure to PCDDs, PCDFs and PCBs
78. Lactation